Across TCGA pan-cancer cohorts, HNRNPA1P12 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated HNRNPA1P12 data layer compared with 22 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher HNRNPA1P12 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated HNRNPA1P12 expression acts as an unfavorable survival marker.

COAD are the cancer types where HNRNPA1P12 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	All	0.140	0.783	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: HNRNPA1P12 tumor-vs-normal RNA expression · all HNRNPA1P12 data types